A简洁的 发表于 2025-3-23 11:05:12

http://reply.papertrans.cn/1/84/8345/8345-11.png

intellect 发表于 2025-3-23 14:03:25

http://reply.papertrans.cn/1/84/8345/8345-12.png

Aspiration 发表于 2025-3-23 20:18:25

Submitted on: 27 April 2006.
Revised on: 20 June 2006.
Accepted on: 28 July 2006.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets

无畏 发表于 2025-3-23 23:50:58

http://reply.papertrans.cn/1/84/8345/8345-14.png

Eeg332 发表于 2025-3-24 04:35:20

Submitted on: 11 June 2012.
Revised on: 25 August 2012.
Accepted on: 08 September 2012.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets

他日关税重重 发表于 2025-3-24 07:06:47

Submitted on: 19 December 2008.
Revised on: 08 April 2009.
Accepted on: 25 April 2009.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets

spondylosis 发表于 2025-3-24 13:06:40

http://reply.papertrans.cn/1/84/8345/8345-17.png

半圆凿 发表于 2025-3-24 15:17:15

http://reply.papertrans.cn/1/84/8345/8345-18.png

专心 发表于 2025-3-24 20:10:46

http://reply.papertrans.cn/1/84/8345/8345-19.png

Monolithic 发表于 2025-3-25 02:57:31

Submitted on: 18 October 2010.
Revised on: 22 January 2011.
Accepted on: 13 February 2011.

___________________Endocrine Metabolic & Immune Disorders-Drug Targets
页: 1 [2] 3 4
查看完整版本: SCIE期刊Endocrine Metabolic & Immune Disorders-Drug Targets 2024/2025影响因子:2.108 (ENDOCR METAB IMMUNE) (1871-5303). (PHARM